English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The NF- κ B is a transcription factor which plays a key role in regulating biological processes. In response to signals, NF- κ B activation occurs via phosphorylation of its inhibitor, which dissociates from the NF- κ B dimer allowing the translocation to the nucleus, inducing gene expression. NF- κ B activation has direct screening applications for drug discovery for several therapeutic indications. Thus, pathway-specific reporter cell systems appear as useful tools to screen and unravel the mode of action of probiotics and natural and synthetic compounds. Here, we describe the generation, characterization, and validation of human epithelial reporter cell lines for functional studies of NF- κ B activation by different pro- and anti-inflammatory agents. Caco-2 and HT-29 cells were transfected with a pNF- κ B-hrGFP plasmid which contains the GFP gene under the control of NF- κ B binding elements. Three proinflammatory cytokines (TNF- α , IL-1 β , and LPS) were able to activate the reporter systems in a dose-response manner, which corresponds to the activation of the NF- κ B signaling pathway. Finally, the reporter cell lines were validated using lactic acid bacteria and a natural compound. We have established robust Caco-2-NF- κ B-hrGFP and HT-29-NF- κ B-hrGFP reporter cell lines which represent a valuable tool for primary screening and identification of bacterial strains and compounds with a potential therapeutic interest.

HT-29 and Caco-2 Reporter Cell Lines for Functional Studies of Nuclear Factor Kappa B Activation